Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adiponectin is secreted by adipose cells and mimics many metabolic actions of insulin. However, mechanisms by which
adiponectin
acts are poorly understood. The vascular action of insulin to stimulate endothelial production of nitric oxide (NO), leading to vasodilation and increased blood flow is an important component of insulin-stimulated whole body glucose utilization. Therefore, we hypothesized that
adiponectin
may also stimulate production of NO in endothelium. Bovine aortic endothelial cells in primary culture loaded with the NO-specific fluorescent dye 4,5-diaminofluorescein diacetate (DAF-2 DA) were treated with lysophosphatidic acid (LPA) (a calcium-releasing agonist) or
adiponectin
(10 microg/ml bacterially produced full-length
adiponectin
). LPA treatment increased production of NO by approximately 4-fold. Interestingly,
adiponectin
treatment significantly increased production of NO by approximately 3-fold. Preincubation of cells with wortmannin (phosphatidylinositol 3-kinase inhibitor) blocked only
adiponectin
- but not LPA-mediated production of NO. Using phospho-specific antibodies, we observed that either
adiponectin
or insulin treatment (but not LPA treatment) caused phosphorylation of both Akt at Ser473 and endothelial nitric-oxide synthase (eNOS) at Ser1179 that was inhibitable by wortmannin. We next transfected bovine aortic endothelial cells with dominant-inhibitory mutants of Akt (Akt-
AAA
) or AMP-activated protein kinase (AMPK) (AMPKK45R). Neither mutant affected production of NO in response to LPA treatment. Importantly, only AMPKK45R, but not Akt-
AAA
, caused a significant partial inhibition of NO production in response to
adiponectin
. Moreover, AMPK-K45R inhibited phosphorylation of eNOS at Ser1179 in response to
adiponectin
but not in response to insulin. We conclude that
adiponectin
has novel vascular actions to directly stimulate production of NO in endothelial cells using phosphatidylinositol 3-kinase-dependent pathways involving phosphorylation of eNOS at Ser1179 by AMPK. Thus, the effects of
adiponectin
to augment metabolic actions of insulin in vivo may be due, in part, to vasodilator actions of
adiponectin
.
...
PMID:Adiponectin stimulates production of nitric oxide in vascular endothelial cells. 1294 90
Abdominal aortic aneurysm
(
AAA
) is a degenerative disease characterized by aortic dilation and rupture leading to sudden death. Currently, no non-surgical treatments are available and novel therapeutic targets are needed to prevent
AAA
. We investigated whether increasing plasma levels of
adiponectin
(
APN
), a pleiotropic adipokine, provides therapeutic benefit to prevent AngII-induced advanced
AAA
in a well-established preclinical model. In the AngII-infused hyperlipidemic low-density lipoprotein receptor-deficient mouse (LDLR
-/-
) model, we induced plasma
APN
levels using a recombinant adenovirus expressing mouse
APN
(AdAPN) and as control, adenovirus expressing green florescent protein (AdGFP).
APN
expression produced sustained and significant elevation of total and high-molecular weight
APN
levels and enhanced
APN
localization in the artery wall. AngII infusion for 8 weeks induced advanced
AAA
development in AdGFP mice. Remarkably,
APN
inhibited the
AAA
development in AdAPN mice by suppressing aortic inflammatory cell infiltration, medial degeneration and elastin fragmentation.
APN
inhibited the angiotensin type-1 receptor (AT1R), inflammatory cytokine and mast cell protease expression, and induced lysyl oxidase (LOX) in the aortic wall, improved systemic cytokine profile and attenuated adipose inflammation. These studies strongly support
APN
therapeutic actions through multiple mechanisms inhibiting AngII-induced
AAA
and increasing plasma
APN
levels as a strategy to prevent advanced
AAA
.
...
PMID:Elevated Adiponectin Levels Suppress Perivascular and Aortic Inflammation and Prevent AngII-induced Advanced Abdominal Aortic Aneurysms. 2765 1